Executive Director at Kentucky Board of Pharmacy
Employing Organization
Team
Decision makers at Kentucky Board of Pharmacy
Administrative Assistant - Licensing, Individuals
General Counsel
Legal Assistant
Key decision makers in the same organization
Organization Signals
Board meetings, strategic plans, and buyer signals from Christopher P. Harlow’s organization
The Protocol Review Committee finalized edits for the protocol regarding pharmacist dispensing of allergic rhinitis therapies, which will be presented for board approval. The committee also reviewed protocols for travel health therapies and colorectal cancer screening but decided to table these items for further research and future discussion at subsequent meetings.
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Verified emails & phones
Accuracy-guaranteed data
Job-change & title updates
Never lose a contact
The board discussed various operational and regulatory matters, including pharmacist reinstatement applications, resident pharmacy facility amendments, and requests for sink waivers and dual pharmacists-in-charge. Committee reports included updates on the KYPRN and the approval of changes to the Emergency Contraception Protocol. Administrative updates covered fee increases for renewals, a staff attorney salary increment, and progress on the policy and procedure manual. The board also addressed legislative and regulatory topics such as the Evidence Collection Policy, licensure eligibility for individuals with criminal records, amendments to several Kentucky Administrative Regulations, and shared services initiatives. A closed session was held regarding an emergency suspension order.
The board retreat focused on several regulatory and policy discussions. Key topics included the reconsideration of comments regarding proposed amendments for 201 KAR 2:440, policy direction concerning the role of pharmacy technicians in loading automated dispensing systems with bar code technology, and future considerations for shared pharmacy services such as Central Fill and Common Electric Fill. Additionally, the board reviewed a presentation on the Standard of Care regulatory model, noting the importance of stakeholder collaboration.
The board meeting focused on reviewing written comments regarding proposed regulation amendments for the Legend Drug Repository (201 KAR 2:440). Actions were taken on six specific comments, including rejecting proposals to allow handling fees for donated drugs and the donation of drug samples. The board approved changes to expiration date criteria, adopted an amendment to align the definition of unopened tamper-evident packaging with United States Pharmacopeia standards, and voted to strike the subsection regarding substitution authority for equivalent drugs.
Extracted from official board minutes, strategic plans, and video transcripts.
Organization signals
Board meetings and buying signals
Salesforce & HubSpot sync
Native two-way integration
